These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 12522661)
1. Alendronate and etidronate do not regulate interleukin 6 and 11 synthesis in normal human osteoblasts in culture. Engel E; Serrano S; Mariñoso ML; Lloreta J; Ulloa F; Nogués X; Diez-Pérez A; Carbonell J Calcif Tissue Int; 2003 Mar; 72(3):228-35. PubMed ID: 12522661 [TBL] [Abstract][Full Text] [Related]
2. [Bisphosphonates stimulate the production of basic fibroblast growth factor and the formation of bone marrow precursors of osteoblasts. New findings about their mechanism of action]. Giuliani N; Pedrazzoni M; Passeri G; Negri G; Impicciatore M; Girasole G Minerva Med; 1998; 89(7-8):249-58. PubMed ID: 9824986 [TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates inhibit IL-6 production by human osteoblast-like cells. Giuliani N; Pedrazzoni M; Passeri G; Girasole G Scand J Rheumatol; 1998; 27(1):38-41. PubMed ID: 9506876 [TBL] [Abstract][Full Text] [Related]
4. IL-6 is produced by osteoblasts and induces bone resorption. Ishimi Y; Miyaura C; Jin CH; Akatsu T; Abe E; Nakamura Y; Yamaguchi A; Yoshiki S; Matsuda T; Hirano T J Immunol; 1990 Nov; 145(10):3297-303. PubMed ID: 2121824 [TBL] [Abstract][Full Text] [Related]
5. Alendronate/interleukin-1beta cotreatment increases interleukin-6 in bone and UMR-106 cells: dose dependence and relationship to the antiresorptive effect of alendronate. Sanders JL; Tarjan G; Foster SA; Stern PH J Bone Miner Res; 1998 May; 13(5):786-92. PubMed ID: 9610742 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 messenger RNA expression and interleukin-6 protein secretion in cells isolated from normal human bone: regulation by interleukin-1. Linkhart TA; Linkhart SG; MacCharles DC; Long DL; Strong DD J Bone Miner Res; 1991 Dec; 6(12):1285-94. PubMed ID: 1792940 [TBL] [Abstract][Full Text] [Related]
7. Osteoblast proliferation and maturation by bisphosphonates. Im GI; Qureshi SA; Kenney J; Rubash HE; Shanbhag AS Biomaterials; 2004 Aug; 25(18):4105-15. PubMed ID: 15046901 [TBL] [Abstract][Full Text] [Related]
8. Regulation of interleukin-6 expression in human osteoblastic cells in vitro. Hierl T; Börcsök I; Sommer U; Ziegler R; Kasperk C Exp Clin Endocrinol Diabetes; 1998; 106(4):324-33. PubMed ID: 9792466 [TBL] [Abstract][Full Text] [Related]
9. Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells. Abe Y; Kawakami A; Nakashima T; Ejima E; Fujiyama K; Kiriyama T; Ide A; Sera N; Usa T; Tominaga T; Ashizawa K; Yokoyama N; Eguchi K J Lab Clin Med; 2000 Nov; 136(5):344-54. PubMed ID: 11079461 [TBL] [Abstract][Full Text] [Related]
10. Involvement of PKC-beta in PTH, TNF-alpha, and IL-1 beta effects on IL-6 promoter in osteoblastic cells and on PTH-stimulated bone resorption. Radeff JM; Nagy Z; Stern PH Exp Cell Res; 2001 Aug; 268(2):179-88. PubMed ID: 11478844 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-4 and interleukin-13 potentiate interleukin-1 induced secretion of interleukin-6 in human osteoblast-like cells. Silfverswärd CJ; Frost A; Brändström H; Nilsson O; Ljunggren O J Orthop Res; 2004 Sep; 22(5):1058-62. PubMed ID: 15304279 [TBL] [Abstract][Full Text] [Related]
13. Etidronate inhibits the production of IL-6 by osteoblast-like cells. Olmos JM; De Vega T; Perera L; Riancho JA; Amado JA; González-Macías J Methods Find Exp Clin Pharmacol; 1999 Oct; 21(8):519-22. PubMed ID: 10599049 [TBL] [Abstract][Full Text] [Related]
14. Effects of TGF-beta, TNF-alpha, IL-beta and IL-6 alone or in combination, and tyrosine kinase inhibitor on cyclooxygenase expression, prostaglandin E2 production and bone resorption in mouse calvarial bone cells. Park YG; Kang SK; Kim WJ; Lee YC; Kim CH Int J Biochem Cell Biol; 2004 Nov; 36(11):2270-80. PubMed ID: 15313472 [TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo. Giuliani N; Pedrazzoni M; Negri G; Passeri G; Impicciatore M; Girasole G Bone; 1998 May; 22(5):455-61. PubMed ID: 9600778 [TBL] [Abstract][Full Text] [Related]
16. The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro. Littlewood AJ; Russell J; Harvey GR; Hughes DE; Russell RG; Gowen M Endocrinology; 1991 Sep; 129(3):1513-20. PubMed ID: 1714833 [TBL] [Abstract][Full Text] [Related]
17. Differential activity of kaempferol and quercetin in attenuating tumor necrosis factor receptor family signaling in bone cells. Pang JL; Ricupero DA; Huang S; Fatma N; Singh DP; Romero JR; Chattopadhyay N Biochem Pharmacol; 2006 Mar; 71(6):818-26. PubMed ID: 16434028 [TBL] [Abstract][Full Text] [Related]
18. Chloroquine inhibits production of TNF-alpha, IL-1beta and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes. Jang CH; Choi JH; Byun MS; Jue DM Rheumatology (Oxford); 2006 Jun; 45(6):703-10. PubMed ID: 16418198 [TBL] [Abstract][Full Text] [Related]
19. Production of interleukin-6 in human osteoblasts and human bone marrow stromal cells: evidence that induction by interleukin-1 and tumor necrosis factor-alpha is not regulated by ovarian steroids. Rifas L; Kenney JS; Marcelli M; Pacifici R; Cheng SL; Dawson LL; Avioli LV Endocrinology; 1995 Sep; 136(9):4056-67. PubMed ID: 7649114 [TBL] [Abstract][Full Text] [Related]
20. Increase of cyclooxygenase-2 expression by interleukin 15 in rheumatoid synoviocytes. Min SY; Hwang SY; Jung YO; Jeong J; Park SH; Cho CS; Kim HY; Kim WU J Rheumatol; 2004 May; 31(5):875-83. PubMed ID: 15124245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]